Steven R. Grossman
Affiliations: | Virginia Commonwealth University School of Medicine, Richmond, VA |
Google:
"Steven Grossman"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Madan E, Palma AM, Vudatha V, et al. (2024) Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells. Nature Biotechnology |
Zhang T, Li S, Tan YA, et al. (2024) Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Cancer Letters. 217240 |
Chougoni KK, Park H, Damle PK, et al. (2023) Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma. Oncogenesis. 12: 53 |
Dcona MM, Chougoni KK, Dcona DT, et al. (2023) Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer. Cancer Research Communications |
Zhang T, Li S, Tan YA, et al. (2023) Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Biorxiv : the Preprint Server For Biology |
Jecrois AM, Dcona MM, Deng X, et al. (2020) Cryo-EM Structure of CtBP2 Confirms Tetrameric Architecture. Structure (London, England : 1993) |
Ding B, Yuan F, Damle PK, et al. (2020) CtBP determines ovarian cancer cell fate through repression of death receptors. Cell Death & Disease. 11: 286 |
Oduah EI, Grossman SR. (2020) Harnessing the vulnerabilities of p53 mutants in lung cancer - Focusing on the proteasome: a new trick for an old foe? Cancer Biology & Therapy. 1-10 |
Adashek JJ, Szeto C, Sanborn JZ, et al. (2020) Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities. Journal of Clinical Oncology. 38: 3576-3576 |
Yazbeck V, McConnell I, Harris E, et al. (2020) Abstract B41: Modeling marginal zone lymphomagenesis Cancer Research. 80 |